Publications

• 1 - LC-HRMS based method for suspect/non-targeted screening for biomarkers of chemical exposure in human urine
  Žiga Tkalec, Garry Codling, Jana Klánová, Milena Horvat, Tina Kosjek 06/2022
• 2 - Position paper on management of personal data in environment and health research in Europe
  Govarts Eva, Gilles Liese, Bopp Stephanie, Holub Petr, Matalonga Leslie, Vermeulen Roel, Vrijheid Martine, Beltran Sergi, Hartlev Mette, Jones Sarah, Rodriguez Martin Laura, Standaert Arnout, Swertz Morris A., Theunis Jan, Trier Xenia, Vogel Nina, Van Espen Koert, Remy Sylvie, Schoeters Greet 06/2022
• 3 - Improving the Risk Assessment of Pesticides through the Integration of Human Biomonitoring and Food Monitoring Data: A Case Study for Chlorpyrifos
  Jose V. Tarazona, Maria del Carmen González-Caballero, Mercedes de Alba-Gonzalez, Susana Pedraza-Diaz, Ana Cañas, Noelia Dominguez-Morueco, Marta Esteban-López, Irene Cattaneo, Andromachi Katsonouri, Konstantinos C. Makris, Thorhallur I. Halldorsson, Kristin Olafsdottir, Jan-Paul Zock, Jonatan Dias, Annelies De Decker, Bert Morrens, Tamar Berman, Zohar Barnett-Itzhaki, Christian Lindh, Liese Gilles, Eva Govarts, Greet Schoeters, Till Weber, Marike Kolossa-Gehring, Tiina Santonen, Argelia Castaño 06/2022
• 4 - Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants
  Liese Gilles, Eva Govarts, Laura Rodriguez Martin, Anna-Maria Andersson, Brice M. R. Appenzeller, Fabio Barbone, Argelia Castaño, Dries Coertjens, Elly Den Hond, Vazha Dzhedzheia, Ivan Eržen, Marta Esteban López, Lucia Fábelová, Clémence Fillol, Carmen Franken, Hanne Frederiksen, Catherine Gabriel, Line Småstuen Haug, Milena Horvat, Thórhallur Ingi Halldórsson, Beata Janasik, Nataša Janev Holcer, Réka Kakucs, Spyros Karakitsios, Andromachi Katsonouri, Jana Klánová, Tina Kold-Jensen, Marike Kolossa-Gehring, Corina Konstantinou, Jani Koponen, Sanna Lignell, Anna Karin Lindroos, Konstantinos C. Makris, Darja Mazej, Bert Morrens, L’ubica Palkoviˇcová Murínová, Sónia Namorado, Susana Pedraza-Diaz, Jasmin Peisker, Nicole Probst-Hensch, Loïc Rambaud, Valentina Rosolen, Enrico Rucic, Maria Rüther, Dimosthenis Sarigiannis, Janja Snoj Tratnik, Arnout Standaert, Lorraine Stewart, Tamás Szigeti, Cathrine Thomsen, Hanna Tolonen, Ása Eiríksdóttir, An Van Nieuwenhuyse, Veerle J. Verheyen, Jelle Vlaanderen, Nina Vogel, Wojciech Wasowicz, Till Weber, Jan-Paul Zock, Ovnair Sepai, Greet Schoeters 06/2022
• 5 - Time-trends in human urinary concentrations of phthalates and substitutes DEHT and DINCH in Asian and North American countries (2009–2019)
  Elena Domínguez-Romero, Klára Komprdová, Jiří Kalina, Jos Bessems, Spyros Karakitsios, Dimosthenis A. Sarigiannis, Martin Scheringer 05/2022
• 6 - Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide
  Farida Lamkarkach, Matthieu Meslin, Marike Kolossa-Gehring, Petra Apel, Robert Garnier 05/2022
• 7 - Citizens’ Perception and Concerns on Chemical Exposures and Human Biomonitoring – Results from a Harmonized Qualitative Study in Seven European Countries
  Linda Matisāne, Lisbeth E. Knudsen, Joana Lobo Vicente, Maria Uhl, Andromachi Katsonouri, Annick D. van den Brand, Tamar Berman, Mirjana Dimovska, Eleni Anastasi, Anthi Thoma, Szilvia Középesy, Dragan Gjorgjev, Mirjana Borota Popovska, Shalenie P. den Braver-Sewradj, Tamás Szigeti, Marija Topuzovska Latkovikj, Inese Mārtiņsone, Lāsma Akūlova and Linda Paegle 05/2022
• 8 - Risk Assessment of Dietary Exposure to Organophosphorus Flame Retardants in Children by Using HBM-Data
  Veronika Plichta, Johann Steinwider, Nina Vogel, Till Weber, Marike Kolossa-Gehring, Lubica Palkovičová Murínová, Soňa Wimmerová, Janja Snoj Tratnik, Milena Horvat, Gudrun Koppen, Eva Govarts, Liese Gilles, Laura Rodriguez Martin, Greet Schoeters, Adrian Covaci, Clémence Fillol, Loïc Rambaud, Tina Kold Jensen and Elke Rauscher-Gabernig 05/2022
• 9 - Enhancing Human Biomonitoring Studies through Linkage to Administrative Registers – Status in Europe
  Helle Margrete Meltzer, Tina Kold Jensen, Ondřej Májek, Hanns Moshammer, Maria Wennberg, Agneta Åkesson, and Hanna Tolonen 05/2022
• 10 - HBM4EU Chromates Study: Urinary Metabolomics Study of Workers Exposed to Hexavalent Chromium
  Lucyna Kozłowska, Tiina Santonen, Radu Corneliu Duca, Lode Godderis, Karolina Jagiello, Beata Janasik, An Van Nieuwenhuyse, Katrien Poels, Tomasz Puzyn, Paul T. J. Scheepers, Monika Sijko, Maria João Silva, Anita Sosnowska, Susana Viegas, Jelle Verdonck, Wojciech Wąsowicz, on behalf of HBM4EU Chromates Study Team and on behalf of Statistical Team 04/2022
• 11 - Providing Biological Plausibility for Exposure – Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework
  Annick D. van den Brand, Lola Bajard, Inger-Lise Steffensen, Anne Lise Brantsæter, Hubert A. A. M. Dirven, Jochem Louisse, Ad Peijnenburg, Sophie Ndaw, Alberto Mantovani, Barbara De Santis and Marcel J. B. Mengelers 04/2022
• 12 - Human Biomonitoring Guidance Values (HBM-GVs) for Bisphenol S and Assessment of the Risk Due to the Exposure to Bisphenols A and S, in Europe
  Matthieu Meslin, Claire Beausoleil, Florence Anna Zeman, Jean-Philippe Antignac, Marike Kolossa-Gehring, Christophe Rousselle, Petra Apel 04/2022
• 13 - What is required to combine human biomonitoring and health surveys?
  Hanna Tolonen, Sonja Moore, Dominik Lermen, Ana Virgolino, Lisbeth E Knudsen, Anna-Maria Andersson, Loïc Rambaud, Carla Ancona, Marike Kolossa-Gehring 03/2022
• 14 - Environmental Substances Associated with Chronic Obstructive Pulmonary Disease—A Scoping Review
  Hanna Maria Elonheimo, Tiina Mattila, Helle Raun Andersen, Beatrice Bocca, Flavia Ruggieri, Elsi Haverinen and Hanna Tolonen 03/2022
• 15 - HBM4EU Chromates Study: Determinants of Exposure to Hexavalent Chromium in Plating, Welding and Other Occupational Settings
  Susana Viegas, Carla Martins, Beatrice Bocca, Radia Bousoumah, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Ivo Iavicoli, Beata Janasik, Kate Jones, Elizabeth Leese, Veruscka Leso, Sophie Ndaw, An van Nieuwenhuyse, Katrien Poels, Simo P. Porras, Flavia Ruggieri, Maria João Silva, Jelle Verdonck, Wojciech Wasowicz, Paul T. J. Scheepers, Tiina Santonen andHBM4EU Chromates Study Team 03/2022
• 16 - The Association between ADHD and Environmental Chemicals—A Scoping Review
  Sonja Moore, Laura Paalanen, Lisa Melymuk, Andromachi Katsonouri, Marike Kolossa-Gehring, Hanna Tolonen 03/2022
• 17 - Oxidative stress of glyphosate, AMPA and metabolites of pyrethroids and chlorpyrifos pesticides among primary school children in Cyprus
  Konstantinos C. Makris, Nikolaos Efthymiou, Corina Konstantinou, Elena Anastasi, Greet Schoeters, Marike Kolossa-Gehring, Andromachi Katsonouri 03/2022
• 18 - Exposure to non-persistent pesticides, BDNF, and behavioral function in adolescent males: Exploring a novel effect biomarker approach
  Andrea Rodríguez-Carrillo, Shereen C. D’Cruz, Vicente Mustieles, Beatriz Suarez, Fatima Smagulova, Arthur David, Francisco Peinado, Francisco Artacho-Cordon, Luis C. Lopez, Juan P. Arrebola, Nicolas Olea, Mariana F. Fernandez, Carmen Freire 03/2022
• 19 - Using Human Biomonitoring Data to Support Risk Assessment of Cosmetic Ingredients—A Case Study of Benzophenone-3
  Christophe Rousselle, Matthieu Meslin, Tamar Berman, Marjolijn Woutersen, Wieneke Bil, Jenna Wildeman, Qasim Chaudhry 02/2022
• 20 - Bisphenol A and declining semen quality: A systematic review to support the derivation of a reference dose for mixture risk assessments
  Andreas Kortenkamp, Olwenn Martin, Sibylle Ermler, Asma Baig, Martin Scholze 02/2022
• 21 - Proficiency and Interlaboratory Variability in the Determination of Phthalate and DINCH Biomarkers in Human Urine: Results from the HBM4EU Project
  Hans G. J. Mol, Ingrid Elbers, Claudia Pälmke, Daniel Bury, Thomas Göen, Marta Esteban López, Stefanie Nübler, Vincent Vaccher, Jean-Philippe Antignac, Darina Dvoráková, Jana Hajšlová, Amrit Kaur Sakhi, Cathrine Thomsen, Katrin Vorkamp, Argelia Castaño, Holger M. Koch 01/2022
• 22 - In silico deconjugation of glucuronide conjugates enhances tandem mass spectra library annotation of human samples
  Carolin Huber, Martin Krauss, Vera Reinstadler, Sara Denicolò, Gert Mayer, Tobias Schulze, Werner Brack, Herbert Oberacher 01/2022
• 23 - Critical review of analytical methods for the determination of flame retardants in human matrices
  Parvaneh Hajeb, Argelia Castaño, Enrique Cequier, Adrian Covaci, Marta Esteban López, Ana Gonzalez Antuña, Line Småstuen Haug, Luis Alberto Henríquez-Hernández, Lisa Melymuk, Octavio Pérez Luzardo, Cathrine Thomsen, Katrin Vorkamp 01/2022
• 24 - The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU)
  Beatriz Gonzalez-Alzaga, Antonio F. Hernandez, L. Kim Pack, Ivo Iavicoli, Hanna Tolonen, Tiina Santonen, Marco Vinceti, Tommaso Filippini, Hanns Moshammer, Nicole Probst-Hensch, Marike Kolossa-Gehring, Marina Lacasana 12/2021
• 25 - Concentrations and determinants of lead, mercury, cadmium, and arsenic in pooled donor breast milk in Spain
  Freire C, Iribarne-Durán LM, Gil F, Olmedo P, Serrano-Lopez L, Peña-Caballero M, Hurtado JA, Alvarado-González NE, Fernández MF, Peinado FM, Artacho-Cordón F, Olea N. 12/2021
• 26 - HBM4EU Occupational Biomonitoring Study on e-Waste—Study Protocol
  Paul T. J. Scheepers, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Emilie Hardy, Lisbeth E. Knudsen, Elizabeth Leese, Henriqueta Louro, Selma Mahiout, Sophie Ndaw, Katrien Poels, Simo P. Porras, Maria J. Silva, Ana Maria Tavares, Jelle Verdonck, Susana Viegas, Tiina Santonen, HBM4EU e-Waste Study Team 12/2021
• 27 - Interlaboratory Comparison Investigations (ICIs) for human biomonitoring of chromium as part of the quality assurance programme under HBM4EU
  Stefanie Nübler, Moritz Schäfer, Karin Haji-Abbas-Zarrabi, Stefan Markovic, Katarina Markovic, Marta Esteban Lopez, Argelia Castano, Hans Mol, Holger M. Koch, Jean-Philippe Antignac, Jana Hajslova, Cathrine Thomsen, Katrin Vorkamp, Thomas Goen 12/2021
• 28 - Metabolic syndrome and endocrine disrupting chemicals: an overview of exposure and health effects
  Elsi Haverinen, Mariana F. Fernandez, Vicente Mustieles, Hanna Tolonen 12/2021
• 29 - Environmental Substances Associated with Alzheimer’s Disease—A Scoping Review
  Hanna Maria Elonheimo, Helle Raun Andersen, Andromachi Katsonouri, Hanna Tolonen 11/2021
• 30 - AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development
  Florence Jornod, Thomas Jaylet, Ludek Blaha, Denis Sarigiannis, Luc Tamisier, Karine Audouze 10/2021
• 31 - Human Biomonitoring Guidance Values (HBM-GVs) derived for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP)
  Madlen David, Antje Gerofke, Rosa Lange, Marike Kolossa-Gehring, Petra Apel 10/2021
• 32 - Lead (Pb) and neurodevelopment: A review on exposure and biomarkers of effect (BDNF, HDL) and susceptibility
  Claudia Gundacker, Martin Forsthuber, Tamás Szigeti, Réka Kakucs, Vicente Mustieles, Mariana F. Fernandez, Elizabeth Bengtsen, Ulla Vogel, Karin Sørig Hougaard, Anne Thoustrup Saber 10/2021
• 33 - Exploring the relationship between metal exposure, BDNF, and behavior in adolescent males
  Andrea Rodríguez-Carrillo, Vicente Mustieles, Shereen Cynthia D'Cruz, Louis Legoff, Fernando Gil, Pablo Olmedo, IrisReina-Pérez, Antonio Mundo, Marina Molina, Fatima Smagulova, Arthur David, Carmen Freire, Mariana F. Fernández 10/2021
• 34 - BDNF as a potential mediator between childhood BPA exposure and behavioral function in adolescent boys from the INMA-Granada cohort
  Vicente Mustieles, Andrea Rodríguez-Carrillo, Fernando Vela-Soria, Shereen Cynthia D'Cruz, Arthur David, Fatima Smagulova, Antonio Mundo-López, Alicia Olivas-Martínez, Iris Reina-Pérez, Nicolás Olea, Carmen Freire, Juan P. Arrebolam, Mariana F. Fernández 09/2021
• 35 - HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium
  TiinaSantonen, Simo P. Porras, Beatrice Bocca, Radia Bousoumah, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Thomas Göen, Emilie Hardy, Ivo Iavicoli, Beata Janasik, Kate Jones. Elizabeth Leese, Veruscka Leso, Henriqueta Louro, Nicole Majery, Sophie Ndaw, Hermínia Pinhal, Flavia Ruggieri, Maria J. Silva, An van Nieuwenhuyse, Jelle Verdonck, Susana Viegas, Wojciech Wasowicz, Ovnair Sepai, Paul T.J. Scheepers. HBM4EU chromates study team: Kukka Aimonen, Guillaume Antoine, Rob Anzion, Manuella Burgart, Argelia Castaño, Andrea Cattaneo, Domenico Maria Cavallo, Giuseppe De Palma, Flavien Denis, Angela Gambelunghe, Bruno Gomes, Ogier Hanser, Riikka Helenius, Carina Ladeira, Marta Esteban López, Piero Lovreglio, Philippe Marsan, Mathieu Melczer, Ana Nogueira, Elisabeta Pletea, Katrien Poels, Jouko Remes, Edna Ribeiro, Sílvia Reis Santos, Françoise Schaefers, Sally Spankie, Robert Spoek, Mohamed Rizki, Davy Rousset, Maurice van Dael, Henna Veijalainen 09/2021
• 36 - HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity – The HBM4EU survey
  Liese Gilles, Eva Govarts, Loïc Rambaud, Nina Vogel, Argelia Castaño, Marta Esteban López, Laura Rodriguez Martin, Gudrun Koppen, Sylvie Remy, Martine Vrijheid, Parisa Montazeri, Laura Birks, Ovnair Sepai, Lorraine Stewart, Ulrike Fiddicke, Ilse Loots, Lisbeth E. Knudsen, Marike Kolossa-Gehring, Greet Schoeters 08/2021
• 37 - Interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) for flame retardant analysis in biological matrices: Results from the HBM4EU project
  Darina Dvorakova, Jana Pulkrabova, Tomas Gramblicka, Andrea Polachova, Martina Buresova, Marta Esteban López, Argelia Castaño, Stefanie Nübler, Karin Haji-Abbas-Zarrabi, Nadine Klausner, Thomas Göen, Hans Mol, Holger M Koch, Vincent Vaccher, Jean-Philippe Antignac, Line Småstuen Haug, Katrin Vorkamp, Jana Hajslova 07/2021
• 38 - Reproductive Health Risks Associated with Occupational and Environmental Exposure to Pesticides
  Aleksandra Fucic, Radu C. Duca, Karen S. Galea, Tihana Maric, Kelly Garcia, Michael S. Bloom, Helle R. Andersen and John E. Vena 06/2021
• 39 - Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) – Development and results
  Eva Ougier, Catherine Ganzleben, Pierre Lecoq, Jos Bessems, Madlen David, Greet Schoeters, Rosa Lange, Matthieu Meslin, Maria Uhl, Marike Kolossa-Gehring, Christophe Rousselle, Joana Lobo Vicente 06/2021
• 40 - Concentrations of perfluoroalkyl substances in donor breast milk in Southern Spain and their potential determinants
  Serrano L, Iribarne-Durán LM, Suárez B, Artacho-Cordón F, Vela-Soria F, Peña- Caballero M, Hurtado JA, Olea N, Fernández MF, Freire C 06/2021
• 41 - Biomonitoring of occupational exposure to bisphenol A, bisphenol S and bisphenol F: A systematic review
  Radia Bousoumah, Veruscka Leso, Ivo Iavicoli, Pasi Huuskonen, Susana Viegas, Simo P. Porras, Tiina Santonen, Nadine Frery, Alain Robert, Sophie Ndaw 05/2021
• 42 - Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium
  Eva Ougier, Karine Fiore, Christophe Rousselle, Ricardo Assunção, Carla Martins, Jurgen Buekers 04/2021
• 43 - HBM4EU chromates study - Reflection and lessons learnt from designing and undertaking a collaborative European biomonitoring study on occupational exposure to hexavalent chromium.
  Karen S. Galea; Simo P. Porras; Susana Viegas; Beatrice Bocca; Radia Bousoumah; Radu Corneliu Duca; Lode Godderis; Ivo Iavicoli; Beata Janasik; Kate Jones; Lisbeth E. Knudsen; Elizabeth Leese; Veruscka Leso; Henriqueta Louro; Sophie Ndaw; Flavia Ruggieri; Ovnair Sepai; Paul T.J. Scheepers; Maria João Silva; Wojciech Wasowicz; Tiina Santonen 03/2021
• 44 - Interlaboratory Comparison Investigations (ICI) and External Quality Assurance Schemes (EQUAS) for Cadmium in urine and blood: results from the HBM4EU project
  Stefanie Nübler, Marta Esteban López, Argelia Castaño, Hans Mol, Moritz Schäfer, Karin Haji-Abbas-Zarrabi, Daniel Bury, Holger M. Koch, Vincent Vaccher, Jean-Philippe Antignac, Darina Dvorakova, Jana Hajslova, Cathrine Thomsen, Katrin Vorkamp, Thomas Göen 03/2021
• 45 - Urinary metabolites of non-persistent pesticides and serum hormones in Spanish adolescent males.
  Freire C, Suárez B, Vela-Soria F, Castiello F, Reina-Pérez I, Andersen HR, Olea N, Fernández MF 03/2021
• 46 - Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring
  Ana Virgolino; Osvaldo Santos; Joana Costa; Mónica Fialho; Ivo Iavicoli; Tiina Santonen; Hanna Tolonen; Evangelia Samoli; Klea Katsouyanni; Georgios Baltatzis; Flavia Ruggieri; Annalisa Abballe; Ida Petrovičová; Branislav Kolena; Miroslava Šidlovská; Carla Ancona; Ivan Eržen; Ovnair Sepai; Argelia Castaño; Marike Kolossa-Gehring; Ulrike Fiddicke 03/2021
• 47 - Network Analysis to Identify Communities Among Multiple Exposure Biomarkers Measured at Birth in Three Flemish General Population Samples
  Ilse Ottenbros, Eva Govarts, Erik Lebret, Roel Vermeulen, Greet Schoeters, Jelle Vlaanderen 02/2021
• 48 - Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A
  Eva Ougier, Florence Zeman, Jean-Philippe Antignac, Christophe Rousselle, Rosa Lange, Marike Kolossa-Gehring, Petra Apel 04/2021
• 49 - The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals
  Marta Esteban López, Thomas Göen, Hans Mol, Stefanie Nübler, Karin Haji-Abbas-Zarrabi, Holger M. Koch, Monika Kasper-Sonnenberg, Darina Dvorakova, Jana Hajslova, Jean-Philippe Antignac, Vincent Vaccher, Ingrid Elbers, CathrineThomsen, Katrin Vorkamp, Susana Pedraza – Díaz, Marike Kolossa-Gehring, Argelia Castaño 04/2021
• 50 - Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
  Styliani Fragki, Hubert Dirven,Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Zeilmaker & Mirjam Luijten 04/2021
• 51 - Endocrine disrupting potential of replacement flame retardants – review of current knowledge for nuclear receptors associated with reproductive outcomes
  Lola Bajard, Chander K. Negi, Vicente Mustieles, Lisa Melymuk, Stéphane Jomini, Johanna Barthelemy-Berneron, Mariana F. Fernandez, Ludek Blaha 04/2021
• 52 - Children exposure to inorganic and organic arsenic metabolites: A cohort study in Northeast Italy.
  Beatrice Bocca; Anna Pino; Liza Vecchi Brumatti; Valentina Rosolen; Luca Ronfani; Jenny D’Aversa; Flavia Ruggieri; Francesco Petrucci; Gemma Calamandrei; Fabio Barbone; Alessandro Alimonti 05/2020
• 53 - Improving the screening annotation level of pesticide metabolites with combined high-throughput in-vitro incubation and automated LC-HRMS data processing
  Huber C, Müller E, Schulze T, Brack W, Krauss M. 06/2021
• 54 - A human biomonitoring (HBM) Global Registry Framework: Further advancement of HBM research following the FAIR principles
  Zare Jeddi M, Virgolino A, Fantke P, Hopf NB, Galea KS, Remy S, Viegas S, Mustieles V, Fernandez MF, von Goetz N, Vicente JL, Slobodnik J, Rambaud L, Denys S, St-Amand A, Nakayama SF, Santonen T, Barouki R, Pasanen-Kase R, Mol HGJ, Vermeire T, Jones K, Silva MJ, Louro H, van der Voet H, Duca RC, Verhagen H, Canova C, van Klaveren J, Kolossa-Gehring M, Bessems J. 09/2021
• 55 - A Suspect Screening Database for Chemicals of Emerging Concern in Exposome Research.
  Meijer J, Lamoree M, Hamers T, Antignac JP, Hutinet S, Debrauwer L, Covaci A, Huber C, Krauss M, Walker DI, Schymanski EL, Vermeulen R, Vlaanderen J. 03/2021
• 56 - Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020
  Célia Ventura, Bruno Costa Gomes, Axel Oberemm, Henriqueta Louro, Pasi Huuskonen, Vicente Mustieles, Mariana F. Fernández, Sophie Ndaw, Marcel Mengelers, Mirjam Luijten, Claudia Gundacker, Maria João Silva 03/2021
• 57 - The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer
  Rosa Lange, Petra Apel, Christophe Rousselle, Sandrine Charles, Fatoumata Sissoko, Marike Kolossa-Gehring, Eva Ougier 03/2021
• 58 - Chemical Exposure: European Citizens’ Perspectives, Trust, and Concerns on Human Biomonitoring Initiatives, Information Needs, and Scientific Results
  Maria Uhl, Ricardo R. Santos, Joana Costa, Osvaldo Santos, Ana Virgolino, David S. Evans, Cora Murray, Maurice Mulcahy, Dorothy Ubong, Ovnair Sepai, Joana Lobo Vicente, Michaela Leitner, Silvia Benda-Kahri and Daniela Zanini-Freitag 02/2021
• 59 - Scoping review – the association between asthma and environmental chemicals
  Tiina Mattila, Tiina Santonen, Helle Raun Andersen, Andromachi Katsonouri, Tamás Szigeti, Maria Uhl, Wojciech Wąsowicz, Rosa Lange, Beatrice Bocca, Flavia Ruggieri, Marike Kolossa-Gehring, Denis A. Sarigiannis and Hanna Tolonen 02/2021
• 60 - Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring
  Noelia Caballero-Casero, Lidia Belova, Philippe Vervliet, Jean-Philippe Antignac, Argelia Castaño, Laurent Debrauwer, Marta Esteban López, Carolin Huber, Jana Klanova, Martin Krauss, Arjen Lommen, Hans G.J. Mol, Herbert Oberacher, Olga Pardo, Elliott J. Price, Vera Reinstadler, Chiara Maria Vitale, Alexander L.N. van Nuijs, Adrian Covaci 01/2021
• 61 - Environmental Substances Associated with Osteoporosis–A Scoping Review
  Hanna Elonheimo, Rosa Lange, Hanna Tolonen and Marike Kolossa-Gehring 01/2021
• 62 - Assessment of chemical mixtures using biomarkers of combined biological activity: A screening study in human placentas
  Andrea Rodríguez-Carrillo, Anna Kjerstine Rosenmai, Vicente Mustieles, Stephan Couderq, Jean-Baptiste Fini, Fernando Vela-Soria, Jose Manuel Molina-Molina, Patricia Ferrando-Marco, Eva Cecilie Bonefeld-Jorgensen, Nicolás Olea, Anne Marie Vinggaard, Mariana F. Fernández 01/2021
• 63 - Towards a systematic use of effect biomarkers in population and occupational biomonitoring
  Maryam Zare Jeddi, Nancy B. Hopf, Susana Viegas, Anna Bal Price, Alicia Paini, Christoph van Thriel, Emilio Benfenati, Sophie Ndaw, Jos Bessems, Peter A. Behnisch, Gabriele Leng, Radu-Corneliu Duca, Hans Verhagen, Francesco Cubadda, Lorraine Brennan, Imran Ali, Arthur David, Vicente Mustieles, Mariana F. Fernandez, Henriqueta Louro, Robert Pasanen-Kase 12/2020
• 64 - Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for cadmium and its compounds
  Farida Lamkarkach, Eva Ougier, Robert Garnier, Claude Viau, Marike Kolossa-Gehring, Rosa Lange, Petra Apel 12/2020
• 65 - A Phased Approach for preparation and organization of human biomonitoring studies
  Ulrike Fiddicke, L. Kim Pack, Hanna Tolonen, Ovnair Sepai, Marta Esteban López, Argelia Castaño, Greet Schoeters, Marike Kolossa-Gehring 12/2020
• 66 - A call for urgent action to safeguard our planet and our health in line with the helsinki declaration
  Jaana I. Halonena, Marina Erhola, Eeva Furman, Tari Haahtela, Pekka Jousilahti, Robert Barouki, Åke Bergman, Nils E. Billo, Richard Fuller, Andrew Haines, Manolis Kogevinas, Marike Kolossa-Gehring, Kinga Krauze, Timo Lanki, Joana Lobo Vicente, Peter Messerli, Mark Nieuwenhuijsen, Riikka Paloniemi, Annette Peters, Karl-Heinz Posch, Pekka Timonen, Roel Vermeulen, Suvi M. Virtanen, Jean Bousquet, Josep M.Antó 12/2020
• 67 - Non-targeted screening methodology to characterise human internal chemical exposure: application to halogenated compounds in human milk.
  Pourchet M, Narduzzi L, Jean A, Guiffard I, Bichon E, Cariou R, Guitton Y, Hutinet S, Vlaanderen J, Meijer J, Le Bizec B, Antignac JP. 12/2020
• 68 - Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative
  Katrin Vorkamp, Argelia Castaño, Jean-Philippe Antignac, Luis D. Boadad, Enrique Cequiere, Adrian Covaci, Marta Esteban López, Line S. Haug, Monika Kasper-Sonnenberg, Holger M. Koch, Octavio Pérez Luzardo, Agnese Osīte, Loïc Rambaud, Maria-Teresa Pinorini, Gabriele Sabbioni, Cathrine Thomsen 11/2020
• 69 - Systematic review of biomonitoring data on occupational exposure to hexavalent chromium.
  Jelle Verdonck; Radu-Corneliu Duca; Karen S. Galea; Ivo Iavicoli; Katrien Poels; Zehra Nur Töreyin; Jeroen Vanoirbeek; Lode Godderis 07/2021
• 70 - Estimating human exposure to pyrethroids' mixtures from biomonitoring data using physiologically based pharmacokinetic modeling.
  Paul Quindroit; Amélie Crépet; Céline Brochot 10/2020
• 71 - Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review
  Sophie A. H. Boesen, Manhai Long, Maria Wielsøe, Vicente Mustieles, Mariana F. Fernandez, Eva C. Bonefeld-Jørgensen 10/2020
• 72 - Receptor-based in vitro activities to assess human exposure to chemical mixtures and related health impacts
  Anne Marie Vinggaard, Eva Cecilie Bonefeld-Jørgensen, Tina Kold Jensen, Mariana F. Fernandez, Anna Kjerstine Rosenmai, Camilla Taxvig, Andrea Rodriguez-Carrillo, Maria Wielsøe, Manhai Long, Nicolas Olea, Jean-Philippe Antignac, Timo Hamers, Marja Lamoree 10/2020
• 73 - Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU
  Madlen David, Gerda Schwedler, Lena Reiber, Hanna Tolonen, Anna-Maria Andersson, Marta Esteban López, Anke Joas, Miriam Schöpel, Alexandra Polcher, Marike Kolossa-Gehring 09/2020
• 74 - Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment
  Petra Apel, Christophe Rousselle, Rosa Lange, Fatoumata Sissoko, Marike Kolossa-Gehring, Eva Ougier 09/2020
• 75 - Biomonitoring as an Underused Exposure Assessment Tool in Occupational Safety and Health Context—Challenges and Way Forward
  Susana Viegas, Maryam Zare Jeddi, Nancy B. Hopf, Jos Bessems, Nicole Palmen, Karen S. Galea, Kate Jones, Peter Kujath, Radu-Corneliu Duca, Hans Verhagen, Tiina Santonen and Robert Pasanen-Kase 08/2020
• 76 - Bisphenol A and its analogues: A comprehensive review to identify and prioritize effect biomarkers for human biomonitoring
  Vicente Mustieles, Shereen Cynthia D'Cruz, Stephan Couderq, Andrea Rodríguez-Carrillo, Jean-Baptiste Fini, Tim Hofer, Inger-Lise Steffensen, Hubert Dirven, Robert Barouki, Nicolás Olea, Mariana F. Fernández, Arthur David 08/2020
• 77 - Assessment of perfluoroalkyl substances in placenta by coupling salt assisted liquid-liquid extraction with dispersive liquid-liquid microextraction prior to liquid chromatography-tandem mass spectrometry
  F.Vela-Soria, J.García-Villanova, V.Mustieles, T.de Haro, J.P.Antignac, M.F.Fernandez 08/2020
• 78 - Biomonitoring of occupational exposure to phthalates: A systematic review
  Nadine Fréry, Tiina Santonen, Simo P. Porras, Aleksandra Fucic, Veruscka Leso, Radia Bousoumah, Radu Corneliu Duca, Mounia El Yamani, Marike Kolossa-Gehring, Sophie Ndaw, Susana Viegas, Ivo Iavicoli 07/2020
• 79 - Bisphenols and oxidative stress biomarkers – Associations found in human studies, evaluation of methods used, and strengths and weaknesses of the biomarkers
  Inger-Lise Steffensen, Hubert Dirven, Stephan Couderq, Arthur David, Shereen Cynthia D'Cruz, Mariana F. Fernández, Vicente Mustieles, Andrea Rodríguez-Carillo, Tim Hofer 05/2020
• 80 - Low doses of Bisphenol S affect post-translational modifications of sperm proteins in male mice
  Hedvika Řimnáčová, Miriam Štiavnická, Jiří Moravec, Marouane Chemek, Yaroslav Kolinko, Olga García-Álvarez, Peter R. Mouton, Azalia Mariel Carranza Trejo, Tereza Fenclová, Nikola Eretová, Petr Hošek, Pavel Klein, Milena Králíčková, Jaroslav Petr & Jan Nevoral 05/2020
• 81 - Biomonitoring of co-exposure to bisphenols by consumers of canned foodstuffs
  Neus González, Montse Marquès, Sara C. Cunha, José O. Fernandes, José L. Domingo, Martí Nadal 05/2020
• 82 - Suspect and non-targeted screening of chemicals of emerging concern for human biomonitoring, environmental health studies and support to risk assessment: From promises to challenges and harmonisation issues
  Marianne Pourchet, Laurent Debrauwer, Jana Klanova, Elliott J. Price, Adrian Covaci, Noelia Caballero-Casero, Herbert Oberacher, Marja Lamoree, Annelaure Damont, François Fenaille, Jelle Vlaanderen, Jeroen Meijer, Martin Krauss, Denis Sarigiannis, Robert Barouki, Bruno Le Bizec, Jean-Philippe Antignac 04/2020
• 83 - Biomonitoring for occupational exposure to diisocyanates: a systematic review
  Bernice Scholten, Laura Kenny, Radu-Corneliu Duca, Anjoeka Pronk, Tiina Santonen, Karen S Galea, Miranda Loh, Katriina Huumonen, Anne Sleeuwenhoek, Matteo Creta, Lode Godderis, Kate Jones 04/2020
• 84 - Relying on repeated biospecimens to reduce the effects of classical-type exposure measurement error in studies linking the exposome to health
  Lydiane Agier, Rémy Slama, Xavier Basagaña 04/2020
• 85 - Towards Harmonized Biobanking for Biomonitoring: A Comparison of Human Biomonitoring-Related and Clinical Biorepositories
  Dominik Lermen, Frederik Gwinner, Martina Bartel-Steinbach, Sabine C. Mueller, Jens K. Habermann, Matharoo-Ball Balwir, Elke Smits, Ana Virgolino, Ulrike Fiddicke, Marika Berglund, Agneta Åkesson, Anna Bergstrom, Karin Leander, Milena Horvat, Janja Snoj Tratnik, Manuel Posada de la Paz, Argelia Castaño Calvo, Marta Esteban López, Hagen von Briesen, Heiko Zimmermann and Marike Kolossa-Gehring 04/2020
• 86 - Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells
  Katrin Kreuzer, Linda Böhmert, Deema Alhalabi, Thorsten Buhrke, Alfonso Lampen, Albert Braeuning 03/2020
• 87 - Comparison of polycyclic aromatic hydrocarbon metabolite concentrations in urine of mothers and their newborns
  Katerina Urbancova, Darina Dvorakova, Tomas Gramblicka, Radim J. Sram, Jana Hajslova, Jana Pulkrabova 03/2020
• 88 - A European proposal for quality control and quality assurance of tandem mass spectral libraries
  Herbert Oberacher, Michael Sasse, Jean-Philippe Antignac, Yann Guitton, Laurent Debrauwer, Emilien L. Jamin, Tobias Schulze, Martin Krauss, Adrian Covaci, Noelia Caballero-Casero, Kathleen Rousseau, Annelaure Damont, François Fenaille, Marja Lamoree, Emma L. Schymanski 03/2020
• 89 - Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose–Response Meta-analysis
  Giorgia Adani, Tommaso Filippini, Lauren A. Wise, Thorhallur I. Halldorsson, Ludek Blaha and Marco Vinceti 03/2020
• 90 - Testing for thyroid hormone disruptors, a review of non-mammalian in vivo models
  Stephan Couderq, Michelle Leemans, Jean-Baptiste Fini 03/2020
• 91 - Time course of phthalate cumulative risks to male developmental health over a 27-year period: Biomonitoring samples of the German Environmental Specimen Bank
  Petra Apel, Andreas Kortenkamp, Holger M. Koch, Nina Vogel, Maria Rüther, Monika Kasper-Sonnenberg, Andre Conrad, Thomas Brüning, Marike Kolossa-Gehring 02/2020
• 92 - Transcriptomic effect marker patterns of genotoxins – a comparative study with literature data
  Katrin Kreuzer, Falko Frenzel, Alfonso Lampen, Albert Braeuning, Linda Böhmert 12/2019
• 93 - Pesticides with potential Thyroid Hormone-Disrupting Effects: A review of recent data
  Michelle Leemans, Stephan Couderq, Barbara Demeneix and Jean-Baptiste Fini 12/2019
• 94 - Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment
  Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, Thomas Backhause, Tina Bahadori, Robert Barouki, Werner Brack, Mark T.D. Cronin, Barbara Demeneix, Susanne HougaarD Bennekou, Jacobvan Klaveren, Carsten Kneuer, Marike Kolossa-Gehring, Erik Lebret, Leo Posthuma, Lena Reiber, Cynthia Rider, Joëlle Rüegg, Giuseppe Testa, Bart van der Burg, Hilkovan der Voet, A. Michael Warhurst, Bob van de Water, Kunihiko Yamazaki, Mattias Öberg, Åke Bergman 11/2019
• 95 - Deciphering adverse outcome pathway network linked to Bisphenol F using text mining and systems toxicology approaches
  Marylène Rugard, Xavier Coumoul, Jean-Charles Carvaillo, Robert Barouki, Karine Audouze 10/2019
• 96 - Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium
  Tiina Santonen, Alessandro Alimonti, Beatrice Bocca, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Thomas Göen, Bruno Gomes. Ogier Hanser, Ivo Iavicoli, Beata Janasik, Kate Jones, Mirja Kiilunen, Holger M. Koch, Elizabeth Leese, Veruscka Leso, Henriqueta Louro, Sophie Ndaw, Simo P. Porras, Alain Robert, Flavia Ruggieri, Paul T.J. Scheepers, Maria J.Silva, Susana Viegas, Wojciech Wasowicz, Argelia Castano, Ovnair Sepai 07/2019
• 97 - A review of phthalate pharmacokinetics in human and rat: what factors drive phthalate distribution and partitioning?
  Elena Domínguez-Romero, Martin Scheringer 06/2019
• 98 - Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study
  Loreta Strumylaite, Rima Kregzdyte, Algirdas Bogusevicius, Lina Poskiene, Dale Baranauskiene and Darius Pranys 06/2019
• 99 - A strategy to validate a selection of human effect biomarkers using adverseoutcome pathways: Proof of concept for phthalates and reproductive effects
  Kirsten Baken, Nathalie Lambrechts, Greet Schoeters, et al. 05/2019
• 100 - Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future
  Henriqueta Louro, Tiina Santonen, et al. 05/2019
• 101 - Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach
  Jean-Charles Carvaillo, Robert Barouki, Xavier Coumoul and Karine Audouze 04/2019
• 102 - Linking past uses of legacy SVOCs with today's indoor levels and human exposure
  Hale Demirtepe, Lisa Melymuk, Miriam L. Diamond, Lola Bajard, Šimon Vojta, Roman Prokeš, Ondřej Sáňka, Jana Klánová, Ľubica Palkovičová Murínová, Denisa Richterová, Vladimíra Rašplová, Tomáš Trnovec 04/2019
• 103 - Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways
  Lola Bajard, Lisa Melymuk and Ludek Blaha 02/2019
• 104 - Physiology-based toxicokinetic modeling in the frame of the European Human Biomonitoring Initiative
  Sarigiannis, D.A., Karakitsios, S., Dominguez-Romero, E., Papadaki, K., Brochot, C., Kumar, V., Schumacher, M., Sy, M., Mielke, H., Greiner, M., Mengelers, M., Scheringer, M. 01/2019
• 105 - Annotating Non-targeted LC-HRMS/MS Data with Two Complementary Tandem Mass Spectral Libraries
  Herbert Oberacher, Vera Reinstadler, Marco Kreidl, Michael A. Stravs, Juliane Hollender and Emma L. Schymanski 12/2018
• 106 - Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population
  Jurgen Buekers et. al 09/2018
• 107 - Current EU research activities on combined exposure to multiple chemicals
  Stephanie K. Bopp et. al, 08/2018
• 108 - Thyroid-disrupting chemicals and brain development: an update
  Bilal B Mughal, Jean-Baptiste Fini, Barbara A Demeneix 04/2018
• 109 - Human biomonitoring in Israel: Recent results and lessons learned
  Tamar Bermana et. al, 12/2017

• 1 - Bisphenol A shapes children's brain and behavior: towards an integrated neurotoxicity assessment including human data
  Vicente Mustieles, Mariana F. Fernández 06/2020
• 2 - Deliverable 8.1 Description of the national programmes - a strategy to collect EU wide HBM data
  Greet Schoeters (VITO) et al. 04/2018
• 3 - Deliverable 7.3 1st prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling
  Ulrike Fiddicke (UBA) et. al, 02/2018
• 4 - Additional Deliverable AD 8.2 Research plan for chromates study under HBM4EU
  Sophie Ndaw (INRS) et. al, 01/2018
• 5 - Additional Deliverable 16.1 Screening methods inventory
  Mariane Pourchet-Gellez (INRA) et. al, 12/2017
• 6 - Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances
  Marja Lamoree (VU-IVM) et. al, 12/2017
• 7 - Deliverable 10.2 Statistical Analysis Plan
  Martine Vrijheid (ISGlobal) et. al, 12/2017
• 8 - Deliverable 12.2 Report on the optimal methodology for exposure reconstruction from HBM data
  Milena Horvat (JSI) et. al, 12/2017
• 9 - Deliverable 16.1 Prioritised list of known emerging chemicals
  Jelle Vlaanderen (IRAS) et. al, 12/2017
• 10 - Deliverable 5.3 Scoping paper on the development of an indicator on chemical exposure in the European population
  Xenia Trier (EEA) et. al, 12/2017
• 11 - Deliverable 7.1 Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM
  Ana Virgolino (FMUL) et. al, 12/2017
• 12 - Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands
  Dominik Lermen (IBMT) et. al, 12/2017
• 13 - Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan
  Jelle Vlaanderen (IRAS) et. al, 12/2017
• 14 - Additional Deliverable 5.1 A (phased) plan for action: how structurered multi-actor dialogues on human biomonitoring results can facilitate targeted policy action (generic canvas for HBM4EU)
  Ann Crabbé (UAntwerpen) et. al, 12/2017
• 15 - Deliverable 5.2 1st substance-group specific derivation of EU-wide health-based guidance values
  Petra Apel (UBA) et. al, 12/2017
• 16 - Deliverable 2.4 2018 Programme of training activities, materials and capacity building mechanisms
  Paul T.J. Scheepers (RUMC) et. al, 12/2017
• 17 - Deliverable 5.1 Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals
  Tiina Santonen (FIOH) et. al, 11/2017
• 18 - Deliverable 9.4 The Quality Assurance/Quality Control Scheme in the HBM4EU project
  Thomas Göen (IPASUM) et. al, 11/2017
• 19 - Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU?
  Madlen David (UBA) et. al, 10/2017
• 20 - Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances
  Alberto Gotti (IUSS) et. al, 10/2017
• 21 - Deliverable 9.3 Database of candidate laboratories for the 1st prioritisation round of substances
  Octavio Pérez Luzardo (ULPGC) et. al, 10/2017
• 22 - Deliverable 2.3 2018 Strategy for the communication and dissemination of HBM4EU results
  Catherine Ganzleben (EEA) et. al, 10/2017
• 23 - Deliverable 14.1 Criteria for prioritisation of biomarkers of effect
  Nicolás Olea (UGR) et. al, 10/2017
• 24 - Additional Deliverable 11.2 Criteria for feasibility studies
  Hanna Tolonen (THL) et. al, 09/2017
• 25 - Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board
  Lena Reiber (UBA) et. al, 09/2017
• 26 - Deliverable 9.2 Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritisation round of substances
  Cathrine Thomsen (NIPH) et. al, 09/2017
• 27 - Deliverable 4.3 Prioritisation strategy and criteria
  Jean-Nicholas Ormsby (ANSES) et. al, 08/2017
• 28 - Additional Deliverable 12.2 Roadmap for model PBTK/D model refinement and analysis for priority substances
  Laurent Bodin (ANSES) et. al, 08/2017
• 29 - Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances
  Alberto GOTTI et. al, 07/2017
• 30 - Deliverable 10.1 Data Management Plan, July 2017
  Sylvie Remy (VITO) et. al, 07/2017
• 31 - Annex to Deliverable 10.1 Data Policy, July 2017
  Sylvie Remy (VITO) et. al, 07/2017
• 32 - Deliverable 4.2 Scoping documents on HBM4EU priority substances for 2018, June 2017
  Greet Schoeters (VITO) et. al, 06/2017
• 33 - Additional deliverable 8.1 Report on access to occupational data
  Tiina Santonen (FIOH) et. al, 06/2017
• 34 - Deliverable 13.1 Criteria for the selection of cohort studies, June 2017
  Thorhallur Ingi Halldorsson (UI) et. al, 06/2017
• 35 - Deliverable 6.1 First set of key indicators for HBM4EU, June 2017
  Hans Reynders et. al, 06/2017
• 36 - Deliverable 4.1 Template for the submission of rapid requests, May 2017
  Jean-Nicolas Ormsby (ANSES) et. al, 05/2017

• 1 - Chemical mixtures pose ‘underestimated’ risk to human health say scientists
  Marike Kolossa-Gehring 05/2019
• 2 - RECETOX Newsletter
  Research Centre for Toxic Compounds in the Environment (RECETOX) 11/2018
• 3 - Human Biomonitoring: Die Umwelt in unserem Koerper
  Oekoskop 12/2017
• 4 - Ikke-regulerede flammehæmmere i indeklimaet – nye eksponerings- og sundhedsrisici?
  Katrin Vorkamp et. al, 12/2017
• 5 - Life cycle-based health risk assessment of plastic waste
  D.A. Sarigiannis et. al, 12/2017
• 6 - Guest blog from the European Environment Agency (EEA): Human Biomonitoring for Europe
  Health and Environment Alliance 11/2017
• 7 - Bringing together raptor collections in Europe for contaminant research and monitoring in relation to chemicals regulations
  Paola Movalli et. al, 09/2017
• 8 - ECHA Newsletter 2017 - Issue 3
  European Chemicals Agency 09/2017
• 9 - The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective
  Fiona Sewell et. al, 08/2017
• 10 - Workshop Report HBM4EU: Nordic workshop for scientists and regulatory agencies discussing HBM4EU - the European human biomonitoring initiative
  Knudsen, Lisbeth E. and Hansen, Pernille Winton 08/2017
• 11 - Human biomonitoring pilot study DEMOCOPHES in Germany: Contribution to a harmonized European approach
  Gerda Schwedler et al. 06/2017